commercial airlines and air navigation service providers have to carry out random drug tests on at least 10 per cent of their flight crew and air traffic controllers every year.
This move could cost $299 million a year for Indian pharma players.
Move follows a spate of international regulatory enforcements on Indian drug firms.
The 550,000 unorganised drug traders in the country are readying to take on the entry of corporate houses like Anil Dhirubhai Ambani Group
The patent department made this declaration on August 16 after Novartis had failed to respond to its queries within the prescribed time.
Even as the domestic pharmaceutical industry is exploring new markets in Latin America and the Commonwealth of Independent States, exports to countries in Africa are declining.
Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.
Wockhardt said it is launching the product immediately in the US market.
Court has barred generic drugmaker Cipla Ltd from making or selling a cheaper copy of Novartis AG's respiratory drug Onbrez domestically.
The fees for facility inspection of foreign companies have been reduced
Intelligence Bureau officers say the problem lies with the government treating narcotics and terrorism as two separate problems, with different law-enforcing agencies for each, and this ends up in defeating the purpose. Vicky Nanjappa reports.
The profit margins of multinational companies importing medicines into India have been hit with the National Pharmaceutical Pricing Authority starting strict scrutiny of price approval applications for imported products.
Ranbaxy Laboratories on Thursday launched a generic version of Prasugrel, used in treating heart diseases, from Daiichi Sankyo portfolio in India as part of strategy to launch drugs from the parent company's stable.
The drug is licensed to Ranbaxy Laboratories from Cipher Pharmaceuticals Inc of Mississauga, Ontario. It is currently protected by two issued patents listed in the FDA's approved drug products list, which expire in September 2021, the company said in a statement.
The government has permitted Teva Pharmaceuticals of Israel and its Dutch subsidiary to together invest $8 million to acquire Regent Drugs from J&K Drugs and Pharmaceuticals.\n\n\n\n
Sixty firms' business worth Rs 1,000 crore at stake.
Pfizer, the world's largest drug company, and Wyeth have sued Daiichi Sankyo-owned Ranbaxy Laboratories in a US court for infringing the patent rights of Wyeth's drug, Rapamune.
Import alert on unit-6 facility might be lifted by FDA by Sept.
The South African government and large pharmaceutical companies are in combat mode regarding the proposed national policy on intellectual property that hopes to improve access to medicines for the poorer sections of the population.
A new report says laws crimp Medicare's ability to control costs on cancer, leading to a 267% increase in drug spending over seven years
Pharma major Wockhardt on Wednesday said it has launched Tamsulosin capsules, indicated for problem of prostate enlargement, in the US market on the day one of the expiry of patent covering the drug.
The court had earlier said that clinical trials of untested drugs on humans require certain mandatory standards to be followed and had also directed the government to put in place a mechanism to monitor them.
Swiss pharmaceutical major Hoffmann-La Roche's patents rights over Hepatitis C drug Pegasys has been challenged by public interest groups at the Indian Patent Office.
10 non-bank and non-finance stocks from the BSE500 Index universe that offer an optimal blend of low valuation, reasonably robust revenue and earnings growth in recent quarters, a strong balance sheet, and most importantly, positive cash flow from their operations.
The First Information Report registered by the ATS also named Anees Ibrahim, Dawood's younger brother and another fugitive.
The Indian drug industry's dream of coming out with an own new chemical entity or an originally researched new drug has received a big boost. Balaglitazone, the diabetic drug molecule being developed by Dr Reddy's Laboratories, has showed encouraging results in the final lap of human clinical trials.
NPPA suggests expanding the list of essential medicines whose prices are controlled
A shocking revelation that banking giants HSBC and Standard Chartered are suspected to have laundered money for drug cartels has prompted an in-depth inquiry by Indian investigation agencies.
European regulators have estimated that consumers are paying up to 20 per cent more for medicines in some cases.
Negotiations for a trade deal between India and the UK have run into fresh controversy, after the proposals under a leaked chapter of the deal on intellectual property (IP) are believed to put access to affordable, lifesaving generic medicines from India at risk. According to the draft IP chapter put out by an international trade portal bilaterals.org, the UK is seeking continuous extension of patent period and rights through small tweaks in the drug, known as evergreening. This may prevent patents from expiring, impacting cheaper drug availability and its production by Indian generic drug manufacturers.
We don't expect any big changes in on excise duty and custom duty rates, except in life saving drugs.
The government is creating a database of traditional Indian drugs aimed at preventing wrongful patenting of drugs, including medicinal plants. This is being done to prevent misappropriation of knowledge about our ancient heritage and wrongful patenting of drugs," Minister of State for Health and Family Welfare Panabaaka Lakshmi said. Speaking at the International Herbal Summit and Expo, Lakshmi said the efficacy of medicinal plants in India needs to be documented.
The Department of Pharmaceuticals has submitted a freight subsidy scheme for exporters to the Commerce Ministry so that they could take alternate routes and avoid transit through Europe, which is a shorter route with better connectivity.
FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte
